Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection.
Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection. Blood. 2019 06 27; 133(26):2800-2802.